Lactoferrin ameliorates myocardial fibrosis by inhibiting inflammatory response via the AMPK/NF-κB pathway in aged mice
Authors:
- Ruiyu ChenRCRuiyu Chen
- Lishan HuangLHLishan Huang
- Wenrong ZhengWZWenrong Zheng
- Meilian ZhangMZMeilian Zhang
- Zhiming XinZXZhiming Xin
- Libin LiuLLLibin Liu
- Zhou ChenZCZhou Chen
Open Access
- 11 May 2022
- journal article
- research article
- Published by Elsevier in Journal of Functional Foods
- Vol. 93
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathwayActa Pharmacologica Sinica, 2012
- AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling networkAgeing Research Reviews, 2012
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespanJournal of Molecular Medicine, 2011
- Transforming Growth Factor-βCirculation: Heart Failure, 2011
- Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1Journal of Biological Chemistry, 2010
- Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathwayCardiovascular Research, 2010
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Human lactoferrin upregulates expression of KDR/Flk‐1 and stimulates VEGF‐A‐mediated endothelial cell proliferation and migrationFEBS Letters, 2006
- Human Apo-Lactoferrin Enhances Angiogenesis Mediated by Vascular Endothelial Growth Factor A in vivoJournal of Vascular Research, 2004
- Drug Therapy in the ElderlySouthern Medical Journal, 1992